Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates

Vaccine

Volumn 35, Issue 1, 2017, Pages 164-169

  Rutten, Lila J Finney ^a   St Sauver, Jennifer L ^a   Beebe, Timothy J ^a,b   Wilson, Patrick M ^a   Jacobson, Debra J ^a   Fan, Chun ^a   Breitkopf, Carmen Radecki ^a   Vadaparampil, Susan T ^c   Jacobson, Robert M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Clinician barriers to vaccination; HPV vaccination completion; HPV vaccination initiation; Human papillomavirus vaccination; Parental barriers to vaccination

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CLINICIAN BARRIER; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; INCIDENCE; NONHUMAN; PARENT; PEDIATRIC NURSE PRACTITIONER; PEDIATRICIAN; PERCEIVED PARENTAL BARRIER; PERCEPTION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; VACCINATION; WART VIRUS; ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CHILD; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PHYSICIAN; PSYCHOLOGY; QUESTIONNAIRE; UTILIZATION; VACCINATION COVERAGE;

ADOLESCENT; ADULT; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PHYSICIANS; SURVEYS AND QUESTIONNAIRES; VACCINATION; VACCINATION COVERAGE;

EID: 84999791277     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.11.012     Document Type: Article

References (19)

1. [1] Viens, L.J., Henley, S.J., Watson, M., Markowitz, L.E., Thomas, C.C., Thompson, T.D., et al. Human papillomavirus-associated cancers – United States, 2008–2012. MMWR Morb Mortal Wkly Rep 65:26 (2016), 661–666.
2. [2] Markowitz, L.E., Dunne, E.F., Saraiya, M., Lawson, H.W., Chesson, H., Unger, E.R., et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommun Rep Mar 56:RR-2 (2007), 1–24 Mar 23.
3. [3] Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L.D., Curtis, C.R., MacNeil, J., et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years – United States, 2015. MMWR Morb Mortal Wkly Rep 65:33 (2016), 850–858.
4. [4] Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011 Dec 23; 60(50): p. 1705–8.
5. [5] Holman, D.M., Benard, V., Roland, K.B., Watson, M., Liddon, N., Stokley, S., Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168:1 (2014), 76–82.
6. [6] Vadaparampil, S.T., Kahn, J.A., Salmon, D., Lee, J.H., Quinn, G.P., Roetzheim, R., et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine 29:47 (2011), 8634–8641.
7. [7] Vadaparampil, S.T., Malo, T.L., Kahn, J.A., Salmon, D.A., Lee, J.H., Quinn, G.P., et al. Physicians’ human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med 46:1 (2014), 80–84.
8. [8] Rocca, W.A., Yawn, B.P., St Sauver, J.L., Grossardt, B.R., Melton, L.J. 3rd., History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 87:12 (2012), 1202–1213.
9. [9] Kurland, L.T., Molgaard, C.A., The patient record in epidemiology. Sci Am 245:4 (1981), 54–63.
10. [10] Melton, L.J. 3rd, History of the Rochester Epidemiology Project. Mayo Clin Proc 71:3 (1996), 266–274.
11. [11] St. Sauver, J.L., Grossardt, B.R., Yawn, B.P., Meton, L.J., Rocca, W.A., Using a medical records-linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol 173:9 (2011), 1059–1068.
12. [12] Briss, P.A., Rodewald, L.E., Hinman, A.R., Shefer, A.M., Strikas, R.A., Bernier, R.R., et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med 18:1 (2000), 97–140.
13. [13] Bailey, H.H., Chuang, L.T., duPont, N.C., Eng, C., Foxhall, L.E., Merrill, J.K., et al. American Society of Clinical Oncology statement: human papillomavirus vaccination for cancer prevention. J Clin Oncol 34:15 (2016), 1803–1812.
14. [14] Darden, P.M., Thompson, D.M., Roberts, J.R., Hale, J.J., Pope, C., Naifeh, M., et al. Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008–2010. Pediatrics 131:4 (2013), 645–651.
15. [15] Jacobson, R.M., Roberts, J.R., Darden, P.M., Parents’ perceptions of the HPV vaccine: a key target for improving immunization rates. Expert Rev Clin Immunol 9:9 (2013), 791–793.
16. [16] Ferrer, H.B., Trotter, C., Hickman, M., Audrey, S., Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health, 14, 2014, 700.
17. [17] Kester, L.M., Zimet, G.D., Fortenberry, J.D., Kahn, J.A., Shew, M.L., A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J 17:5 (2013), 879–885.
18. [18] Ogilvie, G., Anderson, M., Marra, F., McNeil, S., Pielak, K., Dawar, M., et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med, 7(5), 2010, e1000270.
19. [19] Cho, Y.I., Johnson, T.P., Vangeest, J.B., Enhancing surveys of health care professionals: a meta-analysis of techniques to improve response. Eval Health Prof 36:3 (2013), 382–407.